Myofibroblast presence in apparently normal mucosa adjacent to oral squamous cell carcinoma associated with chronic tobacco/areca nut use: evidence for field cancerization

References

• Kim ES, Hong WK, Khuri FR. Chemoprevention of aerodigestive tract cancers. Annu Rev Med 2002;53:223–43.
   PubMedGoogle Scholar
• Thompson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis. Int J Oral Maxillofac Surg 2002;31:262–6.
   PubMedGoogle Scholar
• Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implication of multicentric origin. Cancer 1953;6:963–8.
   PubMed Web of Science ®Google Scholar
• Gabriel DD, Jakupiak PJ, Machin M, Parr R. Clinical implications and utility of field cancerisation. Cancer Cell Int 2007;7:2.
   PubMedGoogle Scholar
• van Oijen MG, Slootweg PJ. Oral Field Cancerization: carcinogen-induced independent events or micrometastic deposits? Cancer Epidemiol Biomarkers Prev 2000;9:249–56.
   PubMedGoogle Scholar
• Angadi PV, Savita JK, Rao SS, Sivaranjini Y. Oral field cancerisation: current evidence and future perspectives. Oral Maxillofac Surg 2012;16:171–80.
   PubMedGoogle Scholar
• Ronnov Jessen L, Bissel MJ. Breast Cancer by proxy: can the microenvironment be both the cause and consequence? Trends Mol Med 2009;15:5–13.
   PubMedGoogle Scholar
• Desmouliere A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004;48:509–17.
   PubMed Web of Science ®Google Scholar
• Shimoda M, Mellody KT, Orimo A. Carcinoma associated fibroblasts are a rate -limiting determinant for tumor progression. Semin Cell Dev Biol 2010;21:19–25.
   PubMed Web of Science ®Google Scholar
• Ziober AF, Falls EM, Ziober BL. The extracellular matrix in oral squamous cell carcinoma: friend or foe? Head Neck 2006;28:740–9.
   Google Scholar
• Beacham DA, Cukierman E. Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. Semin Cancer Biol 2005;15:329–41.
   PubMed Web of Science ®Google Scholar
• El-Gazzar R, Macluskey M, Ogden GR. Evidence for a field change effect based on angiogenesis in the oral mucosa? A brief report. Oral Oncol 2005;41:25–30.
   PubMedGoogle Scholar
• Trujilo KA, Heaphy CM, Mai M, Vargas KM, Jones AC, Vo P, et al. Markers of fibrosis and epithelial mesenchymal transition demonstrate field cancerisation in histologically normal tissue adjacent to breast tumors. Int J Cancer 2011;129:1310–21.
   PubMedGoogle Scholar
• Kunz-Schugart LA, Knuechel R. Tumor associated fibroblasts (Part 1): active stromal participants in tumor development and progression? Histol Histopathol 2002;17:599–621.
   PubMedGoogle Scholar
• Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddin M. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol 2009;38:625–43.
   Google Scholar
• Orumi A, Weinberg RA. Stromal fibroblasts in cancer: a novel tumor promoting cell type. Cell Cycle 2006;15:1597–601.
   Google Scholar
• Vered M, Dobriyan A, Dayan D, Yahalom R, Talmi Y, Bedrin L, et al. Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer. Cancer Sci 2010;101:274–80.
   PubMed Web of Science ®Google Scholar
• Thode C, Jorgensen TG, Dabelsteen E, Mackenzie I, Dabelsteen S. Significance of myofibroblasts in oral squamous cell carcinoma. J Oral Pathol Med 2011;40:201–7.
   PubMed Web of Science ®Google Scholar
• Kellermann MG, Sobral LM, Da Silva SD, Zecchin KG, Graner E, Lopes MA, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma is associated with poor prognosis. Histopathology 2007;51:849–53.
   PubMedGoogle Scholar
• Boudewijin JM, Braakhuis T, Tabor MT, Kumar JA, Leemans R, Barkenhoff RH, et al. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 2003;63:1727–30.
   PubMedGoogle Scholar
• Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Spieght PM, Marshall JF, et al. Tumor derived TGF-beta 1 modulates myofibroblast differentiation and promotes HGF/SF dependent invasion of squamous cell carcinoma cells. Br J Cancer 2004;90:822–32.
   PubMed Web of Science ®Google Scholar
• Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature 2001;411:373–9.
   Google Scholar
• Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown R. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002;3:349–63.
   PubMed Web of Science ®Google Scholar
• De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429–47.
   PubMed Web of Science ®Google Scholar
• Kellerman MG, Sobral LM, Daniela da Silva S, Zecchin KG, Graner E, Lopes MA, et al. Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 2008;44:509–17.
   PubMedGoogle Scholar
• Marsh D, Suchak K, Mousatim KA, Vallath S, Hopper C, Jerjes W, et al. Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 2011;223:470–81.
   PubMed Web of Science ®Google Scholar
• Kalluri R, Weinberg R. The basics of epithelial mesenchymal transition. J Clin Invest 2009;119:1420–8.
   PubMed Web of Science ®Google Scholar
• Vered M, Allon I, Buchner A, Dayan D. Stromal myofibroblasts accompany modifications in the epithelial phenotype of tongue dysplastic and malignant lesions. Cancer Microenviron 2009;2:49–57.
   PubMedGoogle Scholar
• Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, Shappell S, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848–51.
   PubMed Web of Science ®Google Scholar
• Olumi AF, Grossfield GD, Hayward SW, Carroll PR, Tisty TD, Cunha GR. Carcinoma associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999;59:5002–11.
   PubMed Web of Science ®Google Scholar
• Sappino AP, Skalli O, Jackson B, Schurch W, Gabbiani G. Smooth muscle differentiation in stromal cells of malignant and nonmalignant breast tissue. Int J Cancer 1988;41:707–12.
   PubMed Web of Science ®Google Scholar
• Cintorino M, Bellizi de Marco E, Leoncini P, Tripodi SA, Xu J, Sappino AP, et al. Expression of alpha smooth muscle actin in stromal cells of uterine cervix during epithelial neoplastic changes. Int J Cancer 1991;47:843–6.
   PubMedGoogle Scholar
• Martin M, Pujuget P, Martin F. Role of stromal myofibroblasts infiltrating colon cancer in tumor invasion. Pathol Res Pract 1996;192:712–17.
   PubMed Web of Science ®Google Scholar
• Seifi S, Shafaei S, Shafigh E, Sahabi SM, Ghasemi H. Myofibroblast stromal presence and distribution in squamous epithelial carcinomas, oral dysplasia and hyperkeratosis. Asian Pac J Cancer Prev 2010;11:359–64.
   PubMedGoogle Scholar
• Vered M, Allon I, Buchner A, Dayan D. Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis. Oral Oncol 2007;43:999–1006.
   PubMedGoogle Scholar
• Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006;6:392–401.
   PubMed Web of Science ®Google Scholar
• Ge L, Meng W, Zhou H, Bhowmick N. Could stroma contribute to field cancerisation. Med Hypotheses 2010;75:26–31.
   PubMed Web of Science ®Google Scholar
• Xing F, Saidou J, Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci 2010;15:166–79.
   PubMed Web of Science ®Google Scholar
• Kurose K, Gilley K, Matsumoto S, Watson PH, Zhou XP, Eng C. Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas. Nat Genet 2002;32:355–7.
   PubMed Web of Science ®Google Scholar
• Tuhkanen H, Anttilla M, Kosma VM, Yla Herttuala S, Heinonen S, Kuronen A. Genetic alterations in the peritumoral stromal cells of the malignant and borderline epithelial ovarian tumors as indicated by allelic imbalance on chromosome 3p. Int J Cancer 2004;109:247–52.
   PubMedGoogle Scholar
• Jiang L, Gonda TA, Gamble MV, Salas M, Seshan V, Tu S. Global hypomethylation of genomic DNA in cancer associated myofibroblasts. Cancer Res 2008;68:9900–8.
   PubMedGoogle Scholar
• Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004;6:17–32.
   PubMed Web of Science ®Google Scholar
• Qui W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, et al. No evidence of clonal somatic genetic alterations in cancer associated fibroblasts from human breast and ovarian carcinomas. Nat Genet 2008;40:650–5.
   PubMedGoogle Scholar